A carregar...
Omalizumab: Practical considerations regarding the risk of anaphylaxis
Omalizumab has demonstrated efficacy among patients with moderate to severe persistent allergic asthma, whose symptoms are inadequately controlled with other controller agents. This therapy is generally well tolerated, but there are some safety considerations, the most important of which is the rare...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3006370/ https://ncbi.nlm.nih.gov/pubmed/21129189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-6-32 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|